论文部分内容阅读
肝动脉化疗栓塞术(TACE)是目前公认治疗不能手术切除肝癌的最有效的疗法之一[1],但对合并门脉癌栓肝癌的疗效并不理想。我所采用TACE联合化学免疫疗法治疗38例合并门脉癌栓的肝癌,现将结果报告如下。1 资料与方法1.1 一般资料 74例原发性肝癌患者均为我所内科1995年9月—200
Transcatheter arterial chemoembolization (TACE) is currently recognized as one of the most effective therapies for the treatment of unresectable liver cancer [1], but the efficacy of combined portal vein cancer thrombus in liver cancer is not ideal. I used TACE combined with chemical immunotherapy to treat 38 cases of liver cancer with portal vein tumor thrombosis. The results are reported below. 1 Materials and Methods 1.1 General Information 74 cases of primary liver cancer patients were my department of internal medicine in September 1995 -200